Spatially resolved clonal copy number alterations in benign and malignant tissue.

Erickson A, He M, Berglund E, Marklund M, Mirzazadeh R, Schultz N, Kvastad L, Andersson A, Bergenstråhle L, Bergenstråhle J, Larsson L, Alonso Galicia L, Shamikh A, Basmaci E, Díaz De Ståhl T, Rajakumar T, Doultsinos D, Thrane K, Ji AL, Khavari PA, Tarish F, Tanoglidi A, Maaskola J, Colling R, Mirtti T, Hamdy FC, Woodcock DJ, Helleday T, Mills IG, Lamb AD, Lundeberg J. · 2022

Read Spatially resolved clonal copy number alterations in benign and malignant tissue. by Erickson A, He M, Berglund E, Marklund M, Mirzazadeh R, Schultz N, Kvastad L, Andersson A, Bergenstråhle L, Bergenstråhle J, Larsson L, Alonso Galicia L, Shamikh A, Basmaci E, Díaz De Ståhl T, Rajakumar T, Doultsinos D, Thrane K, Ji AL, Khavari PA, Tarish F, Tanoglidi A, Maaskola J, Colling R, Mirtti T, Hamdy FC, Woodcock DJ, Helleday T, Mills IG, Lamb AD, Lundeberg J. (2022) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc9365699.txt.

Introduction

Erickson and co-authors read cancer family history directly from tissue maps. They inferred DNA copy number changes from spatial gene activity data. Over 120,000 tissue regions were covered across several organs. The prostate got an organ-wide deep look, in both benign and malignant areas.

Copy number patterns split tumors into clear clone groups. Nearby benign tissue held clonal patches of its own. The pattern suggests genome instability starts before tissue looks cancerous. That challenges treatment plans that target only visible tumor spots. The method matches DNA-based family trees built from the same samples. It avoids the bias of picking a few regions by eye. The authors say spatial genome maps can sharpen early cancer detection. Benign tissue, in this view, may already carry the seeds of change.

Catalog record

CREATORErickson A, He M, Berglund E, Marklund M, Mirzazadeh R, Schultz N, Kvastad L, Andersson A, Bergenstråhle L, Bergenstråhle J, Larsson L, Alonso Galicia L, Shamikh A, Basmaci E, Díaz De Ståhl T, Rajakumar T, Doultsinos D, Thrane K, Ji AL, Khavari PA, Tarish F, Tanoglidi A, Maaskola J, Colling R, Mirtti T, Hamdy FC, Woodcock DJ, Helleday T, Mills IG, Lamb AD, Lundeberg J.
YEAR2022
COLLECTIONPAPERS
FORMATTXT
FILE SIZE87 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC9365699

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Spatially resolved clonal copy number alterations in benign and malignant tissue By Andrew Erickson, Mengxiao He, Emelie Berglund, Maja Marklund, Reza Mirzazadeh, Niklas Schultz, Linda Kvastad, Alma Andersson, Ludvig Bergenstråhle, Joseph Bergenstråhle, Ludvig Larsson, Leire Alonso Galicia Published in: Nature DOI: 10.1038/s41586-022-05023-2 ABSTRACT Abstract Defining the transition from benign to malignant tissue is fundamental to improving early diagnosis of cancer1. Here we use a systematic approach to study spatial genome integrity in situ and describe previously unidentified clonal relationships. We used spatially resolved transcriptomics2 to infer spatial copy number variations in >120,000 regions across multiple organs, in benign and malignant tissues. We demonstrate that genome-wide copy number variation reveals distinct clonal patterns within tumours and in nearby benign tissue using an organ-wide approach focused on the prostate. Our results suggest a model for how genomic instability arises in histologically benign tissue that may represent early events in cancer evolution. We highlight the power of capturing the molecular and spatial continuums in a tissue context and challenge the rationale for treatment paradigms, including focal therapy. Subject terms: Cancer genomics, Cancer genomics, Software, Phylogenetics MAIN Mutations can be either inherited or acquired (somatic). Inherited genomic polymorphisms are readily identifiable as these are present in all cells, whereas post-developmental somatic mutations are usually present in only a small fraction of cells3. To obtain spatial information about these rarer non-heritable genetic events, studies have commonly used laser-capture microdissection to retrieve histologically defined (or biomarker-defined) tissue regions or even single cells1,4,5. These studies have an inherent bias as only a limited number of spatial regions or single cells per tissue section can be collected and examined. The possibility to perform spatial genome analysis without being confined by histological boundaries would therefore provide an important contribution to delineating the clonal architecture in tumours and co-existing benign tissue. INFERRED COPY NUMBER VARIATION PREDICTS CLONAL HIERARCHIES Spatially resolved transcriptomics has emerged as a tool for genome-wide analysis of gene expression to explore tissues in an unsupervised manner6. In this study, we infer genome-wide copy number variations (CNVs) from spatially resolved mRNA profiles in situ (Fig. 1a). Gene expression has previously been used to infer CNVs in single cells, successfully identifying regions of chromosomal gain and loss7. Here we expand into a spatial modality, generating CNV calls in each spatial region represented by barcoded spots. First, using unsupervised clustering methods, we sought corroboration that inferred CNV data (obtained using inferCNV7) could mirror DNA-based phylogenies, constructed using simultaneously extracted RNA and DNA from single cells8 (Extended Data Fig. 1a). Next, we attempted to recapitulate published DNA-based phylogenies in prostate cancer using RNA from the same samples9–11 (Extended Data Fig. 1b,c) and identified similarity between automated clone calling and published phylogenies. To ensure that inferCNV7 could robustly capture sufficient and accurate CNV information for individual spots from a multifocal tumour model and enable us to deduce clonal relationships between cells, we designed an in silico system to synthesize a tissue containing multiple clones determined by stochastic copy number mutations in a single artificial chromosome. Using a probabilistic method to generate gene expression from such mutations, we then interrogated the expression data using spatial inferred CNVs (siCNVs), while blind to the underlying ‘ground-truth’ copy number status, and successfully recapitulated both the copy number status and the clonal groupings (Extended Data Fig. 2a–c). [Figure: Organ-wide spatial determination of transcript and CNV status.a, For organ-wide assessment, axial segments of the prostate were divided into 5 × 5 mm2 blocks for spatial transcriptomic analysis with spatially barcoded probes. The resulting spatial gene expression profile was accompanied by an inferred copy number profile supported by spot-by-spot consensus pathology calls. Copy number features were used to detect clonal groups and instruct phylogenetic tree construction. Tissue-specific analyses of multiple phenotypes were performed. b, Histology status for each organ-wide section. Black dashed lines represent the area covered by the spatial transcriptomics array surface. GG, International Society of Urological Pathology (ISUP) Gleason ‘grade group’; PIN, prostatic intra-epithelial neoplasia. c, Spatial distribution of gene expression (see f). d, Spatial distribution of summed copy number events (see g). e, Representative spot-level consensus pathology for section H2_5. Red circles indicate spots with ≥50% cancer cells, white circles indicate spots with ≥50% benign epithelium and black circles indicate spots with ≤50% of a single cell type. The diameter of the circles represents 55 μm. f, UMAP principal-component analysis of GEFs with a representative close-up for section H2_5. g, Total copy number events for each section with a representative close-up for section H2_5.] [Figure: Comparison of phylograms created from whole genome sequencing CNVs and iCNV’s.a, Comparison of single tumour cells with co-isolated DNA and RNA (Han et al., Genome Res 2018). Colours correspond to individual cell lines (yellow: SKBR3, green: HCC827, and light blue: MCF7). Entanglement of the phylograms was 0.11 (an entanglement value of 1 corresponds with full entanglement of two phylograms, whereas an entanglement value of 0 corresponds with no entanglement). b Phylogeny from patient A21, as published and reproduced from Gundem et al., Nature, 2015. Transcript data were available only for a subset of specimens. c, Phylogeny from patient 499, as published and reproduced from Hong et al., Nat. Comms, 2015. Transcript data available for a subset of specimens (used to reproduce phylogenetic tree by inferCNV).] [Figure: Generating and running inferCNV on synthetic data.a, Schematic overview of the generative process used to produce artificial spatial data. 1) First a set of seeding cells (red and blue circles) are placed in a defined tissue domain (square), every seeding cell hosts one unique copy number event. 2) The cells are allowed to “grow” within the tissue domain until the number of cells in the domain exceeds a predetermined number. 3) Mutations in the genome occur stochastically during growth and as a result, subpopulations (indicated by colour) of cells with similar genomic profiles arise. 4) Unoccupied space in the tissue domain is filled with benign cells (no copy number variations), spatial capture locations are placed in a grid over the grown tissue and transcripts are “captured” from the cells overlying each spot. 5) Synthetic spatial expression data is produced together with associated ground truth genomic data (both on spot and cell level). b, Results from applying siCNV (bottom) to a set of synthetic data together with ground truth information (top), only cells residing at spots being annotated as non-benign are shown. Blue indicates a deletion event while red indicates an amplification event. The ground truth shows the genomic profiles for all cells contributing to the spots assigned to a given clone. Comparing the inferred state with the ground truth on a clone 19 level, the average accuracy across genes was 0.90 (standard deviation 0.10) c, Spatial organization of the synthetic data analysed in (b), with thumbnail of the complete cell population in the artificial tissue, each pixel corresponding to a cell. The cells’ intensity levels are proportional to their total number of associated copy number events. Circles represent the spots used to “capture” transcripts. Spots are coloured by their inferred clone identity. Note how Clone 2, predicted to have zero copy number events, is found along the borders of both foci, where there’s a mixture of benign and non-benign cells. d, siCNV outputs from simulated

Read the complete text